Controversies over the staging of α-synuclein pathology in Parkinson’s disease

被引:0
作者
Michail E. Kalaitzakis
Manuel B. Graeber
Stephen M. Gentleman
Ronald K. B. Pearce
机构
[1] Imperial College London,Department of Clinical Neuroscience, Neuropathology Unit
[2] The Athenaeum,undefined
来源
Acta Neuropathologica | 2008年 / 116卷
关键词
Substantia Nigra; Braak Staging; Staging Scheme; Incidental Lewy Body Disease; Lewy Body Disease Case;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 84 条
[1]  
Braak H(2003)Staging of brain pathology related to sporadic Parkinson’s disease Neurobiol Aging 24 197-211
[2]  
Del Tredici K(2006)Pathology associated with sporadic Parkinson’s disease––where does it end? J Neural Transm Suppl 70 89-97
[3]  
Rub U(2002)Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61 413-426
[4]  
de Vos RA(2008)Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease Acta Neuropathol 115 437-444
[5]  
Jansen Steur EN(1991)Ageing and Parkinson’s disease: substantia nigra regional selectivity Brain 114 2283-2301
[6]  
Braak E(2006)Predicting Parkinson’s disease: worthwhile but are we there yet? Pract Neurol 6 272-277
[7]  
Braak H(2007)Parkinson’s disease: a dual-hit hypothesis Neuropathol Appl Neurobiol 33 599-614
[8]  
Muller CM(2003)Alpha-synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution––a pilot study Acta Neuropathol 106 191-201
[9]  
Rub U(1998)Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease Nat Genet 18 106-108
[10]  
Ackermann H(2008)Animal models of Parkinson’s disease progression Acta Neuropathol 115 385-398